Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Current Ratio Over TimeFair Value
Percentile Rank71
3Y CAGR-7.8%
5Y CAGR+37.1%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-7.8%/yr
vs +32.1%/yr prior
5Y CAGR
+37.1%/yr
Recent deceleration
Acceleration
-39.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
4.8x
Strong expansion
Streak
4 yr
Consecutive declineFair Value
PeriodValueYoY Change
20249.14-0.8%
20239.21-11.7%
202210.44-10.5%
202111.66-14.4%
202013.62+621.5%
20191.89-20.1%
20182.36-38.2%
20173.82-22.8%
20164.95-13.7%
20155.74-